DE60332915D1 - Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren - Google Patents

Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren

Info

Publication number
DE60332915D1
DE60332915D1 DE60332915T DE60332915T DE60332915D1 DE 60332915 D1 DE60332915 D1 DE 60332915D1 DE 60332915 T DE60332915 T DE 60332915T DE 60332915 T DE60332915 T DE 60332915T DE 60332915 D1 DE60332915 D1 DE 60332915D1
Authority
DE
Germany
Prior art keywords
alkoxy
acyl
amino
producing
nitrobenzoic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60332915T
Other languages
English (en)
Inventor
Scott Mason Duncan
Augustine Tobi Osuma
Sylvain Daigneault
Michel Bernatchez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of DE60332915D1 publication Critical patent/DE60332915D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
DE60332915T 2002-02-05 2003-02-04 Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren Expired - Lifetime DE60332915D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35477702P 2002-02-05 2002-02-05
PCT/US2003/003437 WO2003066575A1 (en) 2002-02-05 2003-02-04 Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids

Publications (1)

Publication Number Publication Date
DE60332915D1 true DE60332915D1 (de) 2010-07-22

Family

ID=27734420

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60332915T Expired - Lifetime DE60332915D1 (de) 2002-02-05 2003-02-04 Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren

Country Status (11)

Country Link
US (2) US7227037B2 (de)
EP (1) EP1472213B1 (de)
JP (1) JP4361375B2 (de)
CN (2) CN1330627C (de)
AT (1) ATE470656T1 (de)
AU (1) AU2003217323A1 (de)
BR (1) BR0307375A (de)
CA (1) CA2475141A1 (de)
DE (1) DE60332915D1 (de)
MX (1) MXPA04007495A (de)
WO (1) WO2003066575A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1330627C (zh) * 2002-02-05 2007-08-08 惠氏公司 N-酰基-2-氨基-4-烷氧基-5-硝基苯甲酸类化合物的合成方法
US7109337B2 (en) 2002-12-20 2006-09-19 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
CA2529611C (en) 2002-12-20 2009-12-15 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
JP2007537238A (ja) 2004-05-14 2007-12-20 ファイザー・プロダクツ・インク 異常細胞増殖の治療のためのピリミジン誘導体
BRPI0511132A (pt) 2004-05-14 2007-11-27 Pfizer Prod Inc derivados de pirimidina e composição farmacêutica compreendendo os mesmos
WO2005111022A1 (en) 2004-05-14 2005-11-24 Pfizer Products Inc. Pyrimidines derivatives for the treatment of abnormal cell growth
BRPI0610142A2 (pt) * 2005-05-25 2011-01-04 Wyeth Corp método para preparar um composto da fórmula (i) ; e método para preparar um ácido da fórmula (vii)
RU2007139544A (ru) * 2005-05-25 2009-06-27 Вайет (Us) Способ получения 3-цианохинолинов и промежуточные соединения, полученные согласно данному способу
CN101203494A (zh) * 2005-05-25 2008-06-18 惠氏公司 合成经取代3-氰基喹啉和其中间物的方法
CA2816957A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
JP6358419B2 (ja) * 2013-12-27 2018-07-18 日産化学工業株式会社 脂環式テトラカルボン酸の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2138000A1 (en) * 1994-01-03 1995-07-04 John E. Starrett, Jr. Retinoid-like compounds
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
CN1190197C (zh) * 2000-03-13 2005-02-23 惠氏控股公司 氰基喹啉用于制备治疗或抑制结肠息肉药物中的用途
CN1330627C (zh) * 2002-02-05 2007-08-08 惠氏公司 N-酰基-2-氨基-4-烷氧基-5-硝基苯甲酸类化合物的合成方法

Also Published As

Publication number Publication date
EP1472213A1 (de) 2004-11-03
US7227037B2 (en) 2007-06-05
US7294740B2 (en) 2007-11-13
US20050085662A1 (en) 2005-04-21
US20070219394A1 (en) 2007-09-20
WO2003066575A1 (en) 2003-08-14
MXPA04007495A (es) 2004-11-10
CN1330627C (zh) 2007-08-08
CA2475141A1 (en) 2003-08-14
CN1628093A (zh) 2005-06-15
EP1472213B1 (de) 2010-06-09
JP4361375B2 (ja) 2009-11-11
ATE470656T1 (de) 2010-06-15
JP2005517005A (ja) 2005-06-09
BR0307375A (pt) 2004-12-07
CN101050189A (zh) 2007-10-10
AU2003217323A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
DE60328492D1 (de) Verfahren zur erzeugung von nanoteilchen
DE60330341D1 (de) Verfahren zur herstellung von wabenstrukturen
ATE417107T1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des pts-g
DE60210697D1 (de) Verfahren zur Produktion von L-Aminosäuren mittels Bakterien der Gattung Escherichia
DE602004028370D1 (de) Verfahren zur bilderzeugung, bilderzeugungsgerät, zwischenelement, und verfahren zur modifizierung der oberfläche des zwischenelementes
DE60237184D1 (de) Verfahren zur Erzeugung von Bewegungen
DE60232605D1 (de) Verfahren zur herstellung von durchblasgetrocknetem tissueprodukt mit abdampfrückgewinnung
DE60125384D1 (de) Verfahren zur herstellung von gipsbauplatten mit erhöhter bruchfestigkeit
ATE337270T1 (de) Verfahren zur herstellung von eisenoxiden
ATE452894T1 (de) Verfahren zur herstellung von salzen von 4-ää5- ä(cyclopropylamino)carbonylü-2- methylphenylüaminoü-5-methyl-n-propylpyrroloä2, - füä1,2,4ütriazin-6-carboxamid und damit hergestellte neue stabile formen
DE60326628D1 (de) Dorn und verfahren zur herstellung von stents
DE60332915D1 (de) Verfahren zur herstellung von n-acyl-2-amino-4-alkoxy-5-nitrobenzoesäuren
DE60324813D1 (de) Verfahren zur Herstellung von Wellenleitern
DE10197137T1 (de) Verfahren zur Herstellung von Mikrostrukturen
DE10195201T1 (de) Verfahren zur Herstellung von Kaliumfluorniobat-Kristallen sowie Kaliumfluorniobat-Kristalle
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE301634T1 (de) Verfahren zur herstellung von alpha- hydroxycarbonsäureamiden
DE60329305D1 (de) VERFAHREN ZUR HERSTELLUNG VON FLUORCARBONSuUREN
ATE274599T1 (de) Verfahren zur enzymatischen racematspaltung von aminomethyl-aryl-cyclohexanol-derivaten
DE60314113D1 (de) Verfahren zur herstellung von phenylorganosiliciumzwischenprodukten
ATE386027T1 (de) Verfahren zur herstellung von valsartan
DE60017795D1 (de) Verfahren zur produktion von pyridinderivaten
DE60318444D1 (de) Verfahren zur herstellung von nevirapin
ATE509899T1 (de) Verfahren zur rückgewinnung von cumol
ATE341558T1 (de) Verfahren zur herstellung von topiramate